Bridgeway Capital Management’s Armata Pharmaceuticals ARMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$290K Hold
44,682
0.01% 983
2026
Q1
$458K Hold
44,682
0.01% 838
2025
Q4
$281K Hold
44,682
0.01% 950
2025
Q3
$133K Hold
44,682
﹤0.01% 1071
2025
Q2
$84.9K Hold
44,682
﹤0.01% 1095
2025
Q1
$65.2K Sell
44,682
-25,000
-36% -$49.8K ﹤0.01% 1101
2024
Q4
$129K Sell
69,682
-5,700
-8% -$12.8K ﹤0.01% 1080
2024
Q3
$179K Sell
75,382
-15,000
-17% -$38.3K ﹤0.01% 1088
2024
Q2
$249K Sell
90,382
-20,000
-18% -$57.1K 0.01% 1006
2024
Q1
$461K Hold
110,382
0.01% 948
2023
Q4
$358K Sell
110,382
-50,000
-31% -$118K 0.01% 1023
2023
Q3
$481K Sell
160,382
-33,300
-17% -$89.3K 0.01% 881
2023
Q2
$221K Hold
193,682
0.01% 1113
2023
Q1
$323K Hold
193,682
0.01% 988
2022
Q4
$240K Buy
193,682
+80,000
+70% +$208K 0.01% 1041
2022
Q3
$480K Hold
113,682
0.01% 905
2022
Q2
$442K Hold
113,682
0.01% 908
2022
Q1
$556K Hold
113,682
0.01% 907
2021
Q4
$623K Sell
113,682
-8,718
-7% -$36.4K 0.01% 923
2021
Q3
$443K Buy
122,400
+9,000
+8% +$34.3K 0.01% 1071
2021
Q2
$450K Buy
113,400
+65,000
+134% +$273K 0.01% 1096
2021
Q1
$231K Buy
+48,400
New +$238K ﹤0.01% 1268

Other funds holding ARMP

Bridgeway Capital Management's ARMP Position: Q2 2026 in Review

Bridgeway Capital Management held its Armata Pharmaceuticals (ARMP) position steady in Q2 2026 at 44,682 shares worth $290K. The position accounts for 0.01% of the portfolio, ranked #983.

Bridgeway Capital Management first reported a position in ARMP in Q1 2021 and has held it in 22 quarters since. The position peaked at $623K in Q4 2021. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Bridgeway Capital Management held 44,682 shares of Armata Pharmaceuticals worth $290K as of Q2 2026.
  • Bridgeway Capital Management left its Armata Pharmaceuticals share count unchanged in Q2 2026.
  • Armata Pharmaceuticals made up 0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #983 holding.
  • Bridgeway Capital Management first reported a position in Armata Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Bridgeway Capital Management's Armata Pharmaceuticals position peaked at $623K in Q4 2021.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.